TB-500: Dosage, Benefits & Research Guide
Also known as: Thymosin Beta-4 fragment, TB4-Frag
What is TB-500?
TB-500 is the synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide present in virtually all human and animal cells. Its primary mechanism of action centers on sequestering G-actin monomers, which promotes actin polymerization and cell migration essential for tissue repair. TB-500 also upregulates expression of laminin-5, a key component of the basement membrane, and activates Akt (protein kinase B) signaling, which research indicates promotes cell survival and inhibits apoptosis. Published studies have demonstrated TB-500's wound healing properties in dermal repair models (Malinda et al., Journal of Investigative Dermatology, 1999) and corneal epithelium regeneration. In equine research, Thymosin Beta-4 has been extensively studied for tendon and ligament repair, with published veterinary trials showing accelerated recovery timelines. The peptide's anti-inflammatory properties appear to operate through suppression of NF-kB and reduction of pro-inflammatory cytokines including IL-1beta and TNF-alpha. Compared to BPC-157, TB-500 has a broader tissue distribution and systemic migration capability, making it a preferred research compound for widespread inflammatory conditions rather than localized injury models. The two peptides target complementary repair mechanisms, which is why they are frequently combined in research protocols. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 28 days. TB-500 is investigated by regenerative medicine centers, veterinary research institutions, and cardiology labs studying post-ischemic tissue recovery.
TB-500 Research Applications
In published and preclinical research, TB-500 has been studied across the following areas:
- Angiogenesis and blood vessel formation
- Wound closure and tissue regeneration
- Collagen synthesis and scar reduction
- Anti-inflammatory activity in joints
TB-500 in Research: Reconstitution & Study Concentrations
TB-500 corresponds to an active fragment of thymosin beta-4, a G-actin-sequestering peptide studied for cell migration, angiogenesis and tissue-repair endpoints. Preclinical protocols express concentrations per model system; there is no established human dose. The lyophilized peptide is reconstituted with bacteriostatic water for laboratory use. Research use only — not for human consumption.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculatorHow TB-500 Compares
Researchers frequently evaluate TB-500 alongside related compounds:
- TB-500 vs BPC-157 — the classic repair-peptide comparison